Cargando…

Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease?

Detalles Bibliográficos
Autores principales: Staessen, Jan A., Janssens, Stefan, Van de Werf, Frans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790104/
https://www.ncbi.nlm.nih.gov/pubmed/35112113
http://dx.doi.org/10.1016/j.ijcrp.2021.200100
_version_ 1784639919694544896
author Staessen, Jan A.
Janssens, Stefan
Van de Werf, Frans
author_facet Staessen, Jan A.
Janssens, Stefan
Van de Werf, Frans
author_sort Staessen, Jan A.
collection PubMed
description
format Online
Article
Text
id pubmed-8790104
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87901042022-02-01 Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease? Staessen, Jan A. Janssens, Stefan Van de Werf, Frans Int J Cardiol Cardiovasc Risk Prev Case Reports Invited Commentary Elsevier 2021-09-25 /pmc/articles/PMC8790104/ /pubmed/35112113 http://dx.doi.org/10.1016/j.ijcrp.2021.200100 Text en © 2021 Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Reports Invited Commentary
Staessen, Jan A.
Janssens, Stefan
Van de Werf, Frans
Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease?
title Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease?
title_full Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease?
title_fullStr Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease?
title_full_unstemmed Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease?
title_short Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease?
title_sort do clinical trial data suggest a role for sglt2-inhibitors in primary prevention of heart failure and chronic kidney disease?
topic Case Reports Invited Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790104/
https://www.ncbi.nlm.nih.gov/pubmed/35112113
http://dx.doi.org/10.1016/j.ijcrp.2021.200100
work_keys_str_mv AT staessenjana doclinicaltrialdatasuggestaroleforsglt2inhibitorsinprimarypreventionofheartfailureandchronickidneydisease
AT janssensstefan doclinicaltrialdatasuggestaroleforsglt2inhibitorsinprimarypreventionofheartfailureandchronickidneydisease
AT vandewerffrans doclinicaltrialdatasuggestaroleforsglt2inhibitorsinprimarypreventionofheartfailureandchronickidneydisease